Table 8.6c

Immunosuppression Use: Maintenance Between Discharge

and One Year Posttransplant, 1993 to 2002

Recipients with Kidney-Pancreas Transplants

		Year of Transplant
		1993	1994	1995	1996	1997	1998	1999	2000	2001	2002
Transplants		661	748	919	860	853	972	943	914	891	905
Tx With Follow-up Immunosuppression Info		600	674	859	797	802	900	881	857	833	855
Corticosteroids	Category Usage	98.3%	98.2%	99.3%	100.0%	99.9%	99.7%	99.5%	95.7%	93.5%	89.1%
	Steroids	98.3%	98.2%	99.3%	100.0%	99.9%	99.7%	99.5%	95.7%	93.5%	89.1%
Cyclosporine	Category Usage	98.5%	83.2%	66.9%	61.9%	48.6%	35.8%	30.8%	22.9%	16.9%	13.2%
	Cyclosporin	97.8%	81.3%	33.3%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	7.7%	9.3%	31.7%	12.4%	8.7%	4.0%	4.9%	2.9%	1.9%	1.3%
	Neoral	1.0%	2.1%	40.6%	59.3%	46.4%	34.0%	28.3%	20.7%	12.5%	9.4%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.2%	2.1%	3.6%	3.5%
	Eon	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.4%	0.0%
Tacrolimus	Category Usage	3.8%	27.9%	46.7%	50.2%	62.0%	75.3%	80.7%	84.4%	89.3%	89.4%
	FK506	3.8%	27.9%	46.7%	50.2%	62.0%	75.3%	80.7%	84.4%	89.3%	89.4%
Antimetabolites	Category Usage	97.3%	93.3%	88.5%	93.9%	95.6%	96.9%	95.8%	87.5%	80.3%	81.2%
	Azathioprine	97.3%	92.9%	57.2%	21.7%	13.7%	11.9%	8.3%	6.2%	3.0%	2.3%
	Mycophenolate mofetil	0.3%	2.1%	46.3%	82.8%	90.1%	93.3%	93.1%	85.6%	79.8%	80.1%
	Cytoxan	0.2%	0.6%	0.8%	0.4%	0.1%	0.6%	0.3%	0.2%	0.1%	0.1%
Other	Category Usage	0.0%	0.0%	0.0%	0.0%	0.1%	0.9%	4.8%	20.5%	30.9%	28.1%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.1%	0.9%	4.8%	20.5%	30.9%	28.1%

Source: OPTN/SRTR Data as of May 3, 2004.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.